Cempra (CEMP) Showing Signs Of A Dead Cat Bounce Today

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Cempra ( CEMP) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Cempra as such a stock due to the following factors:

  • CEMP has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $33.5 million.
  • CEMP has traded 52,643 shares today.
  • CEMP is up 4.4% today.
  • CEMP was down 5.7% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in CEMP with the Ticky from Trade-Ideas. See the FREE profile for CEMP NOW at Trade-Ideas

More details on CEMP:

Cempra, Inc., a clinical-stage pharmaceutical company, focuses on developing antibiotics to meet medical needs in the treatment of bacterial infectious diseases in North America. Currently there are 9 analysts that rate Cempra a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for Cempra has been 876,500 shares per day over the past 30 days. Cempra has a market cap of $1.5 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.07 and a short float of 7.7% with 2.56 days to cover. Shares are up 44.1% year-to-date as of the close of trading on Monday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Biotech Premarket Movers: Cempra, Tesaro, Editas

Biotech Premarket Movers: Cempra, Blueprint Medicines, Aralez

Biotech Premarket Movers: Cempra, Novavax, Ionis

Biotech Premarket Movers: BioCryst, Sangamo, Cempra